Back to Journals » OncoTargets and Therapy » Volume 13

Case report

Ruxolitinib Plus Decitabine Effectively Treats Myelodysplastic Syndrome/Myeloproliferative Neoplasm, Unclassifiable, by Decreasing the Variant Allele Frequency of KRAS

       
Total article views   HTML views PDF downloads Totals
4,542 Dovepress* 3,881+ 720 4,601
PubMed Central* 661 128 789
Totals 4,542 848 5,390
*Since 9 October 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed and Google Scholar